ArticleExploration of targeted anti-tumor therapy2023

Acryl-3,5-bis(2,4-difluorobenzylidene)-4-piperidone targeting cellular JUN proto-oncogene, AP-1 transcription factor subunit inhibits head and neck squamous cell carcinoma progression.

Levi Arnold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.